This report was originally published on August. 1, 2015. It is a part of the series "Risk/Reward." Of the four new anticoagulant drugs billed as alternatives to warfarin, Eliquis is the only one that ...
Results highlighted in two oral presentations at the American Society of Hematology Annual Meeting In a second oral presentation, results from a sub-group analysis of the primary study were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback